Pheochromocytoma differential diagnosis: Difference between revisions
No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
Line 33: | Line 33: | ||
* '''Low-risk patients''': | * '''Low-risk patients''': | ||
** 24-hour [[urinary]] fractionated [[catecholamines]] and [[Metanephrine|metanephrines]] | ** 24-hour [[urinary]] fractionated [[catecholamines]] and [[Metanephrine|metanephrines]]<sup>[[Pheochromocytoma laboratory findings#cite note-pmid12574179-4|[4]]]</sup> | ||
|- | |- | ||
|Pseudopheochromocytoma<ref name="pmid102187452">{{cite journal| author=Mann SJ| title=Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment. | journal=Arch Intern Med | year= 1999 | volume= 159 | issue= 7 | pages= 670-4 | pmid=10218745 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10218745 }}</ref><ref name="pmid10218745">{{cite journal| author=Mann SJ| title=Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment. | journal=Arch Intern Med | year= 1999 | volume= 159 | issue= 7 | pages= 670-4 | pmid=10218745 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10218745 }}</ref><ref name="pmid8824124">{{cite journal| author=Mann SJ| title=Severe paroxysmal hypertension. An automatic syndrome and its relationship to repressed emotions. | journal=Psychosomatics | year= 1996 | volume= 37 | issue= 5 | pages= 444-50 | pmid=8824124 | doi=10.1016/S0033-3182(96)71532-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8824124 }}</ref><ref name="pmid17921824">{{cite journal| author=Sharabi Y, Goldstein DS, Bentho O, Saleem A, Pechnik S, Geraci MF et al.| title=Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma. | journal=J Hypertens | year= 2007 | volume= 25 | issue= 11 | pages= 2286-95 | pmid=17921824 | doi=10.1097/HJH.0b013e3282ef5fac | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17921824 }}</ref> | |Pseudopheochromocytoma<ref name="pmid102187452">{{cite journal| author=Mann SJ| title=Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment. | journal=Arch Intern Med | year= 1999 | volume= 159 | issue= 7 | pages= 670-4 | pmid=10218745 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10218745 }}</ref><ref name="pmid10218745">{{cite journal| author=Mann SJ| title=Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment. | journal=Arch Intern Med | year= 1999 | volume= 159 | issue= 7 | pages= 670-4 | pmid=10218745 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10218745 }}</ref><ref name="pmid8824124">{{cite journal| author=Mann SJ| title=Severe paroxysmal hypertension. An automatic syndrome and its relationship to repressed emotions. | journal=Psychosomatics | year= 1996 | volume= 37 | issue= 5 | pages= 444-50 | pmid=8824124 | doi=10.1016/S0033-3182(96)71532-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8824124 }}</ref><ref name="pmid17921824">{{cite journal| author=Sharabi Y, Goldstein DS, Bentho O, Saleem A, Pechnik S, Geraci MF et al.| title=Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma. | journal=J Hypertens | year= 2007 | volume= 25 | issue= 11 | pages= 2286-95 | pmid=17921824 | doi=10.1097/HJH.0b013e3282ef5fac | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17921824 }}</ref> | ||
Line 45: | Line 45: | ||
* [[Flushing]] | * [[Flushing]] | ||
* Duration of attacks ranges from minutes to hours | * Duration of attacks ranges from minutes to hours | ||
* Physical symptoms occur before feeling fear | |||
| | | | ||
Line 54: | Line 55: | ||
|[[Panic attacks]] | |[[Panic attacks]] | ||
| | | | ||
* Paroxysms of increased sympathetic activity | * Paroxysms of increased [[Sympathetic nervous system|sympathetic activity]] | ||
* | * Episodes of fear or panic attacks | ||
* | * [[Chest]] pain | ||
* [[Headache]] | |||
* [[Palpitations]] | |||
* [[Flushing]] | |||
* Response to [[antidepressants]] | |||
* Fear precedes physical symptoms. | |||
| | |||
| | | | ||
Laboratory studies that can exclude medical disorders other than [[panic disorder]] include: | Laboratory studies that can exclude medical disorders other than [[panic disorder]] include: | ||
Line 63: | Line 69: | ||
* [[Serum glucose]] | * [[Serum glucose]] | ||
* [[Cardiac enzymes]] | * [[Cardiac enzymes]] | ||
* Urine toxicology screening | * Urine [[toxicology]] [[Screening (medicine)|screening]] | ||
|- | |- | ||
|Labile hypertension (White coat hypertension) | |Labile hypertension ([[White coat hypertension]]) | ||
| | | | ||
|Ambulatory blood pressure monitoring and patient self-measurement using a home blood pressure monitoring device are being increasingly used to differentiate patients with [[white coat hypertension]] from patients with true hypertension. | * Elevated [[blood pressure]] in a clinical setting but not in other settings<sup>[[Chronic hypertension differential diagnosis#cite note-pmid24107724-1|[1]]]</sup> | ||
| | |||
| | |||
* Ambulatory blood pressure monitoring and patient self-measurement using a home [[blood pressure]] monitoring device are being increasingly used to differentiate patients with [[white coat hypertension]] from patients with true [[hypertension]]. | |||
|- | |- | ||
|Hyperthyroidism | |[[Hyperthyroidism]] | ||
| | | | ||
|[[Goiter|Goiter | * [[Weight loss]] | ||
|Low [[thyroid-stimulating hormone]] (TSH) | * Heat intolerance | ||
* [[Tremors]] | |||
* [[Palpitations]] | |||
* [[Anxiety]] | |||
* Increased [[bowel]] disturbances | |||
* [[Shortness of breath]]<ref name="pmid15963064">{{cite journal| author=Iglesias P, Acosta M, Sánchez R, Fernández-Reyes MJ, Mon C, Díez JJ| title=Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function. | journal=Clin Endocrinol (Oxf) | year= 2005 | volume= 63 | issue= 1 | pages= 66-72 | pmid=15963064 | doi=10.1111/j.1365-2265.2005.02301.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15963064 }}</ref> | |||
| | |||
* [[Goiter|Goiter]] | |||
* Skin [[flushing]] | |||
* [[Proptosis]] | |||
* Increased sensitivity of [[beta receptors]] in the heart to [[catecholamines]]<ref name="pmid20454652">{{cite journal| author=Mintz G, Pizzarello R, Klein I| title=Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. | journal=J Clin Endocrinol Metab | year= 1991 | volume= 73 | issue= 1 | pages= 146-50 | pmid=2045465 | doi=10.1210/jcem-73-1-146 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2045465 }}</ref> due to an effect of [[Thyroid hormone|thyroid hormones]] increase [[cardiac]] work and [[Cardiac Output|output]] | |||
* [[Systolic hypertension]]<ref name="pmid2045465">{{cite journal| author=Mintz G, Pizzarello R, Klein I| title=Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. | journal=J Clin Endocrinol Metab | year= 1991 | volume= 73 | issue= 1 | pages= 146-50 | pmid=2045465 | doi=10.1210/jcem-73-1-146 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2045465 }}</ref> | |||
| | |||
* Low [[thyroid-stimulating hormone]] (TSH) | |||
* High [[Thyroxine|free thyroxine]] (T4) concentration | |||
* High [[triiodothyronine]] (T3) concentration | |||
|- | |- | ||
|[[Renovascular hypertension]] | |[[Renovascular hypertension]] | ||
| | | | ||
* | * Common in individuals < 30 years or > 55 years | ||
* Abrupt onset of [[hypertension]] | * Abrupt onset of [[hypertension]] | ||
* Accelerated [[hypertension]] that was previously well-controlled | * Accelerated [[hypertension]] that was previously well-controlled | ||
* Refractory [[hypertension]] to 3 anti-hypertensive medications | * Refractory [[hypertension]] to 3 [[Anti-hypertensive|anti-hypertensive medications]] | ||
* [[ | * [[Headache]] | ||
| | * [[Nausea]] | ||
| | * [[Subconjunctival hemorrhage]] | ||
| | |||
* [[Bruit]] can be heard over the [[abdomen]] | |||
| | |||
* [[Duplex ultrasound|Duplex ultrasonography]] may be used as an initial [[Screening (medicine)|screening]] tool for diagnosis of [[Atherosclerotic disease|atherosclerotic]] [[renal artery stenosis]] | |||
* [[Ultrasonography]] (might not be very accurate in [[obese]] patients or those with [[intestinal]] gas)<sup>[[Renal artery stenosis ultrasound#cite note-pmid23457117-1|[1]]]</sup> | |||
|- | |- | ||
|[[Stroke]] and [[Lateral medullary syndrome|compression of lateral medulla]] ([[Lateral medullary syndrome]]) | |[[Stroke]] and [[Lateral medullary syndrome|compression of lateral medulla]] ([[Lateral medullary syndrome]]) | ||
|Extensive unilateral infarction of the [[brain stem]] in the region of the [[nucleus tractus solitarius]] may result in partial [[Baroreflex|baroreflex dysfunction]], increased sympathetic activity, and neurogenic paroxysmal hypertension | |Extensive unilateral infarction of the [[brain stem]] in the region of the [[nucleus tractus solitarius]] may result in partial [[Baroreflex|baroreflex dysfunction]], increased sympathetic activity, and neurogenic paroxysmal hypertension<ref name="pmid10926969">{{cite journal| author=Phillips AM, Jardine DL, Parkin PJ, Hughes T, Ikram H| title=Brain stem stroke causing baroreflex failure and paroxysmal hypertension. | journal=Stroke | year= 2000 | volume= 31 | issue= 8 | pages= 1997-2001 | pmid=10926969 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10926969 }}</ref> | ||
| | | | ||
|[[Computed tomography|CT]] shows mass compressing [[Lateral medullary syndrome|lateral medulla]] or infarction in the same area | | | ||
* [[Computed tomography|CT]] shows mass compressing [[Lateral medullary syndrome|lateral medulla]] or infarction in the same area | |||
|- | |- | ||
|[[Seizures]] | |[[Seizures]] | ||
|According to type; it may be focal or generalized, clinical or subclinical: | |According to type; it may be focal or generalized, clinical or subclinical: | ||
* | * [[tonic-clonic seizure]]: | ||
* Symptoms occur suddenly and may persist | ** Repetitive twitches of arm and legs | ||
* Muscle tension or tightening that causes twisting of the body, head, arms, or legs | ** Tongue bitting | ||
* | ** [[Loss of consciousness]] | ||
* Mood changes | ** Symptoms occur suddenly and may persist | ||
* Change in sensation of the skin over the arm, leg, or trunk | ** [[Muscle]] tension or tightening that causes twisting of the body, head, arms, or legs | ||
* Vision changes and light flashes | ** [[Amnesia]] | ||
* Tasting a bitter or metallic flavor | ** Mood changes (fear, panic, or laughter) | ||
* | ** Change in sensation of the skin over the arm, leg, or trunk | ||
* [[ | ** Vision changes and light flashes | ||
** [[Hallucination|Hallucinations]] | |||
** Tasting a bitter or metallic flavor | |||
* [[Complex partial seizure]]: | |||
** Confused or dazed and | |||
** Not be able to respond to questions or direction | |||
* [[Absence seizure]]: | |||
** Rapid blinking | |||
** Few seconds of staring into space | |||
| | | | ||
| | | | ||
* Abnormal [[electroencephalography]] | |||
* Positive test without a clinical presentation is called a [[Subclinical seizure|sub-clinical seizure]] | |||
|- | |- | ||
|[[Carcinoid syndrome]] | |[[Carcinoid syndrome]] | ||
|Hypertensive crisis occurs with [[malignant carcinoid syndrome]] <ref name="pmid7969229">{{cite journal| author=Warner RR, Mani S, Profeta J, Grunstein E| title=Octreotide treatment of carcinoid hypertensive crisis. | journal=Mt Sinai J Med | year= 1994 | volume= 61 | issue= 4 | pages= 349-55 | pmid=7969229 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7969229 }}</ref> | |[[Hypertensive crisis]] occurs with [[malignant carcinoid syndrome]]<ref name="pmid7969229">{{cite journal| author=Warner RR, Mani S, Profeta J, Grunstein E| title=Octreotide treatment of carcinoid hypertensive crisis. | journal=Mt Sinai J Med | year= 1994 | volume= 61 | issue= 4 | pages= 349-55 | pmid=7969229 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7969229 }}</ref>. Symptoms include: | ||
* Severe [[chest]] pain | |||
* Severe [[headache]] | |||
* [[Confusion]] and [[blurred vision]] | |||
* [[Nausea and vomiting]] | |||
* Severe [[anxiety]] | |||
* [[Shortness of breath]] | |||
* [[Seizures]] | |||
* Unresponsiveness | |||
| | | | ||
* High urinary excretion of [[5-HIAA]] <ref name="pmid3227292">{{cite journal| author=Sjöblom SM| title=Clinical presentation and prognosis of gastrointestinal carcinoid tumours. | journal=Scand J Gastroenterol | year= 1988 | volume= 23 | issue= 7 | pages= 779-87 | pmid=3227292 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3227292 }}</ref> | * [[Cutaneous]] [[flushing]] | ||
* High urinary excretion of [[serotonin]] <ref name="pmid2421946">{{cite journal| author=Feldman JM| title=Urinary serotonin in the diagnosis of carcinoid tumors. | journal=Clin Chem | year= 1986 | volume= 32 | issue= 5 | pages= 840-4 | pmid=2421946 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2421946 }}</ref> | * [[Venous]] [[telangiectasia]] | ||
* High [[chromogranin]] concentration | * [[Diarrhea]] | ||
* [[Bronchospasm]] | |||
* [[Valvular heart disease|Cardiac valvular lesions]] ([[Tricuspid regurgitation|tricuspid incompetence]]) | |||
| | |||
* High urinary excretion of [[5-HIAA]]<ref name="pmid3227292">{{cite journal| author=Sjöblom SM| title=Clinical presentation and prognosis of gastrointestinal carcinoid tumours. | journal=Scand J Gastroenterol | year= 1988 | volume= 23 | issue= 7 | pages= 779-87 | pmid=3227292 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3227292 }}</ref> | |||
* High urinary excretion of [[serotonin]]<ref name="pmid2421946">{{cite journal| author=Feldman JM| title=Urinary serotonin in the diagnosis of carcinoid tumors. | journal=Clin Chem | year= 1986 | volume= 32 | issue= 5 | pages= 840-4 | pmid=2421946 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2421946 }}</ref> | |||
* High [[chromogranin]] concentration[[Chromogranin|(Chromogranin]](A, B, and C) are proteins that are stored and released with [[peptides]] and [[amines]] in a variety of [[Neuroendocrine cells|neuroendocrine tissues]])<ref name="pmid2316306">{{cite journal| author=Eriksson B, Arnberg H, Oberg K, Hellman U, Lundqvist G, Wernstedt C et al.| title=A polyclonal antiserum against chromogranin A and B--a new sensitive marker for neuroendocrine tumours. | journal=Acta Endocrinol (Copenh) | year= 1990 | volume= 122 | issue= 2 | pages= 145-55 | pmid=2316306 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2316306 }}</ref> | |||
* [[Computed tomography|CT]] is recommended for evaluation of all patients with [[Carcinoid syndrome|carcinoid tumors]].<ref name="pmid19077417">{{cite journal| author=Sundin A, Vullierme MP, Kaltsas G, Plöckinger U, Mallorca Consensus Conference participants. European Neuroendocrine Tumor Society| title=ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. | journal=Neuroendocrinology | year= 2009 | volume= 90 | issue= 2 | pages= 167-83 | pmid=19077417 | doi=10.1159/000184855 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19077417 }}</ref> | * [[Computed tomography|CT]] is recommended for evaluation of all patients with [[Carcinoid syndrome|carcinoid tumors]].<ref name="pmid19077417">{{cite journal| author=Sundin A, Vullierme MP, Kaltsas G, Plöckinger U, Mallorca Consensus Conference participants. European Neuroendocrine Tumor Society| title=ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations. | journal=Neuroendocrinology | year= 2009 | volume= 90 | issue= 2 | pages= 167-83 | pmid=19077417 | doi=10.1159/000184855 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19077417 }}</ref> | ||
|- | |- | ||
|[[Migraine headaches]] | |[[Migraine headaches]] | ||
| | | | ||
* '''Prodrome:''' | |||
** Occurs hours or days before a [[headache]] | |||
* '''[[Aura (symptom)|Aura]]''' | |||
** Immediately precedes the [[headache]] | |||
* Pain phase | |||
** Also known as [[headache]] phase | |||
* Postdrome phase'''<ref name="pmid15447695">{{cite journal| author=Kelman L| title=The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. | journal=Headache | year= 2004 | volume= 44 | issue= 9 | pages= 865-72 | pmid=15447695 | doi=10.1111/j.1526-4610.2004.04168.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15447695 }}</ref>''' | |||
| | | | ||
* [[Red eye|Conjunctival injection]] | * [[Red eye|Conjunctival injection]] | ||
* [[Horner's syndrome]] | * [[Horner's syndrome]]<sup>[[Migraine physical examination#cite note-1|[1]]]</sup> | ||
* [[Adie | * [[Adie's pupil]] <sup>[[Migraine physical examination#cite note-2|[2]]]</sup> | ||
* Cranial/ cervical | * [[Cranial]]/ [[Cervical spine|cervical]] [[muscle]] [[tenderness]] | ||
* | * [[Bruit]] at [[neck]] and [[head]] for clinical signs of [[Cerebral arteriovenous malformation|an arteriovenous malformation]] | ||
|'''[[CT]] is indicated in patients with<sup>[[Migraine CT#cite note-1|[1]]]</sup> | * [[Photosensitivity]] | ||
* Abnormal [[physical examination]] | |'''[[CT]] is indicated in patients with:'''<sup>[[Migraine CT#cite note-1|[1]]]</sup><sup>[[Migraine CT#cite note-pmid24400971-2|[2]]]</sup> | ||
* Abnormal [[physical examination]]: | |||
** Increase of [[headache]]'s frequency | ** Increase of [[headache]]'s frequency | ||
** Poor [[coordination]] | ** Poor [[coordination]] | ||
** [[Focal neurologic signs]] | ** [[Focal neurologic signs]] | ||
** [[Headache]] | ** [[Headache]]<nowiki/>s awakening the patient at nigt<sup>[[Migraine CT#cite note-3|[3]]][[Migraine CT#cite note-4|[4]]]</sup> | ||
* Atypical [[aura]] | * Atypical [[aura]] | ||
* Sudden onset | |||
* Lasting more than 1 hour | |||
* Always on the same side | |||
* With or without [[visual]] symptoms | |||
* [[Migraine]] attacks that begin after 50 years of age | * [[Migraine]] attacks that begin after 50 years of age | ||
'''[[CT]] is not indicated in:''' | '''[[CT]] is not indicated in:''' | ||
Line 144: | Line 205: | ||
|- | |- | ||
|Drugs | |Drugs | ||
|[[Sympathomimetic drug|Sympathomimetic drugs]] that can induce symptoms simulating pheochromocytoma include | |[[Sympathomimetic drug|Sympathomimetic drugs]] that can induce symptoms simulating pheochromocytoma include: | ||
* High-dose [[phenylpropanolamine]] | |||
* [[Cocaine]] | |||
* [[Amphetamine|Amphetamines]] | |||
* Lysergic acid diethylamide ([[Lysergic Acid Diethylamide|LSD]]) | |||
* Phenylcyclidine (PCP)<ref name="pmid11358774">{{cite journal| author=Krentz AJ, Mikhail S, Cantrell P, Hill GM| title=Drug Points: Pseudophaeochromocytoma syndrome associated with clozapine. | journal=BMJ | year= 2001 | volume= 322 | issue= 7296 | pages= 1213 | pmid=11358774 | doi= | pmc=31620 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11358774 }}</ref> | |||
* Combination of a [[Monoamine oxidase inhibitor|monoamine oxidase (MAO) inhibitor]] and ingestion of [[Tyramine|tyramine-containing]] foods.<ref name="pmid3980057">{{cite journal| author=Kuchel O| title=Pseudopheochromocytoma. | journal=Hypertension | year= 1985 | volume= 7 | issue= 1 | pages= 151-8 | pmid=3980057 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3980057 }}</ref> | |||
| | | | ||
* Disturbed consciousness | * Disturbed [[consciousness]] | ||
* Nasal septum perforation in [[cocaine addiction]] | * [[Nasal septum]] perforation in [[cocaine addiction]] | ||
* Needle marks on the skin | * Needle marks on the [[skin]] | ||
* History of [[antidepressants]] intake | * History of [[antidepressants|antidepressant]]<nowiki/>intake | ||
|[[Toxicology screen| | | | ||
* [[Urine]] [[Toxicology screen|toxicology screening]] | |||
|- | |- | ||
|[[Baroreflex|Baroreflex failure]] | |[[Baroreflex|Baroreflex failure]] | ||
| | | | ||
* Marked and frequent fluctuations in [[blood pressure]], <ref name="pmid183225442">{{cite journal| author=Zar T, Peixoto AJ| title=Paroxysmal hypertension due to baroreflex failure. | journal=Kidney Int | year= 2008 | volume= 74 | issue= 1 | pages= 126-31 | pmid=18322544 | doi=10.1038/ki.2008.30 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18322544 }}</ref>with both high and low readings | * Marked and frequent fluctuations in [[blood pressure]],<ref name="pmid183225442">{{cite journal| author=Zar T, Peixoto AJ| title=Paroxysmal hypertension due to baroreflex failure. | journal=Kidney Int | year= 2008 | volume= 74 | issue= 1 | pages= 126-31 | pmid=18322544 | doi=10.1038/ki.2008.30 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18322544 }}</ref> with both high and low readings | ||
* It is caused by hypofunctioning of [[Baroreflex| | * It is caused by hypofunctioning of [[Baroreflex|baroreflexes]] that normally buffer [[blood pressure]] fluctuations | ||
* The disorder is usually a result of injury to [[Baroreceptors|carotid baroreceptors]], with most patients reporting a history of neck irradiation or surgery | * The disorder is usually a result of injury to [[Baroreceptors|carotid baroreceptors]], with most patients reporting a history of neck [[irradiation]] or [[surgery]]<ref name="pmid18322544">{{cite journal| author=Zar T, Peixoto AJ| title=Paroxysmal hypertension due to baroreflex failure. | journal=Kidney Int | year= 2008 | volume= 74 | issue= 1 | pages= 126-31 | pmid=18322544 | doi=10.1038/ki.2008.30 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18322544 }}</ref> | ||
| | |||
| | | | ||
* Neck [[Computed tomography|CT]] scan | |||
|} | |} | ||
{| class="wikitable" | |||
! colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Disease}} | |||
! colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Prominent clinical features}} | |||
! colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Investigations}} | |||
|- | |||
| colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Hyperthyroidism}} | |||
|The main symptoms include: | |||
* [[Palpitations]] | |||
* [[Insomnia]] | |||
* [[Anxiety]] | |||
* [[Weight loss]] | |||
* Heat intolerance | |||
* [[Diarrhea]] | |||
* Depending on the underlying diagnosis, the patient might have [[exophthalmus]] or [[goiter]] | |||
| | |||
* The patient usually has elevated [[T3]] and [[T4]] | |||
* [[TSH]] might be increased or decreased depending on the underlying cause | |||
* [[TSI|Thyroid stimulating antibodies (TSI)]] might be increased in cases of [[Graves’ disease]] | |||
|- | |||
| colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Essential hypertension}} | |||
|Most patients with hypertension are asymptomatic at the time of diagnosis. Common symptoms are listed below: | |||
*[[Headache]] | |||
*[[Blurry vision]] | |||
*[[Dyspnea]] | |||
*[[Epistaxis]] | |||
*[[Tinnitus]] | |||
*[[Fatigue]] | |||
*[[Drowsiness]] | |||
|JNC 7 recommends the following routine laboratory tests before initiation of therapy for hypertension''':''' | |||
*[[ECG|12-Lead electrocardiogram (ECG)]] | |||
*[[Urinalysis]], including urinary albumin excretion or albumin/creatinine ratio | |||
*[[Blood glucose]] | |||
*[[Hematocrit|Blood hematocrit]] | |||
*[[Electrolyte|Serum electrolytes]], especially [[potassium]] | |||
*[[Calcium|Serum calcium]] | |||
*[[Lipid profile]]: [[Total cholesterol]], [[LDL]], [[HDL]], [[triglycerides]] | |||
*[[Creatinine]] or estimated [[GFR]] | |||
|- | |||
| colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Generalized anxiety disorder}} | |||
|According to DSM V, the following criteria should be present to fit the diagnosis of [[generalized anxiety disorder]]: | |||
#The presence of sense of apprehension or fear toward certain activities for most of the days for at least 6 months | |||
#Difficulty to control the apprehension | |||
#Associated restless, fatigue, irritability, difficult concentration, muscle tension or sleep disturbance (only one of these manifestations) | |||
#The anxiety or the physical manifestations must affect the social and the daily life of the patient | |||
#Exclusion of another medical condition or the effect of another administered substance | |||
#Exclusion of another mental disorder causing the symptoms | |||
|<nowiki>-</nowiki> | |||
|- | |||
| colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Menopause}} | |||
|The [[perimenopausal]] symptoms are caused by an overall drop, as well as dramatic but erratic fluctuations, in the levels of [[estrogens]], [[progestin]], and [[testosterone]]. Some of these symptoms such as [[formication]] etc may be associated with the hormone [[withdrawal]] process. | |||
*Vasomotor instability in the form of [[hot flush]]es, including [[sleep hyperhidrosis|night sweats]] and [[Sleep disorder|sleep disturbances]] | |||
*Urogenital atrophy causing [[Itch|itching]], dryness, [[bleeding]], watery discharge, [[Polyuria|urinary frequency]], [[urinary urgency]] and [[urinary incontinence]] | |||
*Skeletal symptoms in the form of [[osteoporosis]] (gradually developing over time), [[arthralgia|artharlgia]], [[myalgia|myalgia]] and [[back pain]] | |||
*Psychological manifestations such as [[Mood disorder|mood disturbance]], [[irritability]], [[Fatigue (medical)|fatigue]], [[memory loss]] and [[Depression (mood)|depression]] | |||
*Sexual disorders: [[Libido|decreased libido]], [[Vaginal lubrication|vaginal dryness]], problems reaching orgasm and [[dyspareunia]] | |||
| | |||
* [[Human chorionic gonadotropin|B-HCG]] should always be done first to rule out [[pregnancy]] especially in women under the age of 45 years | |||
* [[FSH]] can be measured but it can be falsely normal or low | |||
* [[TSH]], [[T3]] and [[T4]] to rule out thyroid abnormalities | |||
* [[Prolactin]] can be measured to rule out [[prolactinoma]] as a cause of [[menopause]] | |||
|- | |||
| colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Opioid withdrawal disorder}} | |||
|According to DSM V, the following criteria should be present to fit the diagnosis of opioid withdrawal: | |||
# Cessation of (or reduction in) [[Opioid use disorders|opioid use]] that has been heavy and prolonged (i.e.,several weeks or longer) or administration of an [[opioid antagonist]] after a period of [[Opioid use disorders|opioid use]]. | |||
# Development of three or more of the following criteria minutes to days after cessation of drug use: [[Dysphoria|dysphoric mood]], [[nausea]] or [[vomiting]], [[muscle aches]], [[Lacrimation]] or [[rhinorrhea]], [[pupillary dilation]], [[piloerection]], or [[sweating]], [[diarrhea]], [[yawning]], [[fever]], and [[insomnia]]. | |||
# The signs or symptoms mentioned above must cause impairment of the daily functioning of the patient. | |||
# The signs or symptoms mentioned above must not be attributed to other medical or mental disorders. | |||
| | |||
* Urine drug screen to rule out any other associated drug abuse | |||
* Routine blood work such as electrolytes and hemoglobin to rule out any associated disease explaining the symptoms | |||
|- | |||
| colspan="1" rowspan="1" style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Pheochromocytoma}} | |||
|The hallmark symptoms of a [[pheochromocytoma]] are those of [[sympathetic nervous system]] hyperactivity, symptoms usually subside in less than one hour and they may include: | |||
*[[Palpitations]] especially in epinephrine producing tumors. | |||
*[[Anxiety]] often resembling that of a [[panic attack]] | |||
*[[Sweating]] | |||
*[[Headaches]] occur in 90 % of patients. | |||
*Paroxysmal attacks of [[hypertension]] but some patients have normal blood pressure. | |||
*It may be asymptomatic and discovered by incidence screening especially [[MEN, type 2|MEN]] patients. | |||
''Please note that not all patients with pheochromocytoma experience all classical symptoms''. | |||
|Diagnostic lab findings associated with pheochromocytoma include: | |||
*Elevated plasma and urinary [[catecholamine]]s and [[metanephrine]]s | |||
*Elevated urinary [[vanillyl mandelic acid]] | |||
|} | |||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 20:19, 15 August 2017
Pheochromocytoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pheochromocytoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Pheochromocytoma differential diagnosis |
Risk calculators and risk factors for Pheochromocytoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2] Mohammed Abdelwahed M.D[3]
Overview
Pheochromocytoma must be differentiated from other causes of paroxysmal hypertension including severe paroxysmal hypertension (pseudopheochromocytoma), panic disorder, factitious hypertension, carcinoid syndrome, migraine headache, hyperthyroidism, renovascular hypertension, hypoglycemia, labile hypertension (White coat hypertension), stroke, compression of the lateral medulla, seizures, baroreflex failure and drugs.
Differentiating pheochromocytoma from other diseases
Pheochromocytoma must be differentiated from other causes of paroxysmal hypertension. The differentials include:
Disease | Symptoms | Signs | Investigations |
---|---|---|---|
Pheochromocytoma | The symptoms of a pheochromocytoma are those of sympathetic nervous systemhyperactivity and include:
|
|
|
Pseudopheochromocytoma[1][2][3][4] | Paroxysmal activation of the sympathetic system causing:
|
| |
Panic attacks |
|
Laboratory studies that can exclude medical disorders other than panic disorder include: | |
Labile hypertension (White coat hypertension) |
|
| |
Hyperthyroidism |
|
|
|
Renovascular hypertension |
|
| |
Stroke and compression of lateral medulla (Lateral medullary syndrome) | Extensive unilateral infarction of the brain stem in the region of the nucleus tractus solitarius may result in partial baroreflex dysfunction, increased sympathetic activity, and neurogenic paroxysmal hypertension[8] |
| |
Seizures | According to type; it may be focal or generalized, clinical or subclinical:
|
| |
Carcinoid syndrome | Hypertensive crisis occurs with malignant carcinoid syndrome[9]. Symptoms include:
|
| |
Migraine headaches |
|
|
CT is indicated in patients with:[1][2]
CT is not indicated in:
|
Drugs | Sympathomimetic drugs that can induce symptoms simulating pheochromocytoma include:
|
|
|
Baroreflex failure |
|
|
Disease | Prominent clinical features | Investigations |
---|---|---|
Hyperthyroidism | The main symptoms include:
|
|
Essential hypertension | Most patients with hypertension are asymptomatic at the time of diagnosis. Common symptoms are listed below: | JNC 7 recommends the following routine laboratory tests before initiation of therapy for hypertension:
|
Generalized anxiety disorder | According to DSM V, the following criteria should be present to fit the diagnosis of generalized anxiety disorder:
|
- |
Menopause | The perimenopausal symptoms are caused by an overall drop, as well as dramatic but erratic fluctuations, in the levels of estrogens, progestin, and testosterone. Some of these symptoms such as formication etc may be associated with the hormone withdrawal process.
|
|
Opioid withdrawal disorder | According to DSM V, the following criteria should be present to fit the diagnosis of opioid withdrawal:
|
|
Pheochromocytoma | The hallmark symptoms of a pheochromocytoma are those of sympathetic nervous system hyperactivity, symptoms usually subside in less than one hour and they may include:
Please note that not all patients with pheochromocytoma experience all classical symptoms. |
Diagnostic lab findings associated with pheochromocytoma include:
|
- ↑ Mann SJ (1999). "Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment". Arch Intern Med. 159 (7): 670–4. PMID 10218745.
- ↑ Mann SJ (1999). "Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment". Arch Intern Med. 159 (7): 670–4. PMID 10218745.
- ↑ Mann SJ (1996). "Severe paroxysmal hypertension. An automatic syndrome and its relationship to repressed emotions". Psychosomatics. 37 (5): 444–50. doi:10.1016/S0033-3182(96)71532-3. PMID 8824124.
- ↑ Sharabi Y, Goldstein DS, Bentho O, Saleem A, Pechnik S, Geraci MF; et al. (2007). "Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma". J Hypertens. 25 (11): 2286–95. doi:10.1097/HJH.0b013e3282ef5fac. PMID 17921824.
- ↑ Iglesias P, Acosta M, Sánchez R, Fernández-Reyes MJ, Mon C, Díez JJ (2005). "Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function". Clin Endocrinol (Oxf). 63 (1): 66–72. doi:10.1111/j.1365-2265.2005.02301.x. PMID 15963064.
- ↑ Mintz G, Pizzarello R, Klein I (1991). "Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment". J Clin Endocrinol Metab. 73 (1): 146–50. doi:10.1210/jcem-73-1-146. PMID 2045465.
- ↑ Mintz G, Pizzarello R, Klein I (1991). "Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment". J Clin Endocrinol Metab. 73 (1): 146–50. doi:10.1210/jcem-73-1-146. PMID 2045465.
- ↑ Phillips AM, Jardine DL, Parkin PJ, Hughes T, Ikram H (2000). "Brain stem stroke causing baroreflex failure and paroxysmal hypertension". Stroke. 31 (8): 1997–2001. PMID 10926969.
- ↑ Warner RR, Mani S, Profeta J, Grunstein E (1994). "Octreotide treatment of carcinoid hypertensive crisis". Mt Sinai J Med. 61 (4): 349–55. PMID 7969229.
- ↑ Sjöblom SM (1988). "Clinical presentation and prognosis of gastrointestinal carcinoid tumours". Scand J Gastroenterol. 23 (7): 779–87. PMID 3227292.
- ↑ Feldman JM (1986). "Urinary serotonin in the diagnosis of carcinoid tumors". Clin Chem. 32 (5): 840–4. PMID 2421946.
- ↑ Eriksson B, Arnberg H, Oberg K, Hellman U, Lundqvist G, Wernstedt C; et al. (1990). "A polyclonal antiserum against chromogranin A and B--a new sensitive marker for neuroendocrine tumours". Acta Endocrinol (Copenh). 122 (2): 145–55. PMID 2316306.
- ↑ Sundin A, Vullierme MP, Kaltsas G, Plöckinger U, Mallorca Consensus Conference participants. European Neuroendocrine Tumor Society (2009). "ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations". Neuroendocrinology. 90 (2): 167–83. doi:10.1159/000184855. PMID 19077417.
- ↑ Kelman L (2004). "The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs". Headache. 44 (9): 865–72. doi:10.1111/j.1526-4610.2004.04168.x. PMID 15447695.
- ↑ Krentz AJ, Mikhail S, Cantrell P, Hill GM (2001). "Drug Points: Pseudophaeochromocytoma syndrome associated with clozapine". BMJ. 322 (7296): 1213. PMC 31620. PMID 11358774.
- ↑ Kuchel O (1985). "Pseudopheochromocytoma". Hypertension. 7 (1): 151–8. PMID 3980057.
- ↑ Zar T, Peixoto AJ (2008). "Paroxysmal hypertension due to baroreflex failure". Kidney Int. 74 (1): 126–31. doi:10.1038/ki.2008.30. PMID 18322544.
- ↑ Zar T, Peixoto AJ (2008). "Paroxysmal hypertension due to baroreflex failure". Kidney Int. 74 (1): 126–31. doi:10.1038/ki.2008.30. PMID 18322544.